182 related articles for article (PubMed ID: 14978217)
1. Human topoisomerase IIalpha: targeting to subchromosomal sites of activity during interphase and mitosis.
Agostinho M; Rino J; Braga J; Ferreira F; Steffensen S; Ferreira J
Mol Biol Cell; 2004 May; 15(5):2388-400. PubMed ID: 14978217
[TBL] [Abstract][Full Text] [Related]
2. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
Mo YY; Beck WT
Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
[TBL] [Abstract][Full Text] [Related]
3. Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.
Meyer KN; Kjeldsen E; Straub T; Knudsen BR; Hickson ID; Kikuchi A; Kreipe H; Boege F
J Cell Biol; 1997 Feb; 136(4):775-88. PubMed ID: 9049244
[TBL] [Abstract][Full Text] [Related]
4. Co-localization of chicken DNA topoisomerase IIalpha, but not beta, with sites of DNA replication and possible involvement of a C-terminal region of alpha through its binding to PCNA.
Niimi A; Suka N; Harata M; Kikuchi A; Mizuno S
Chromosoma; 2001 May; 110(2):102-14. PubMed ID: 11453553
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation.
Adachi N; Nomoto M; Kohno K; Koyama H
Gene; 2000 Mar; 245(1):49-57. PubMed ID: 10713444
[TBL] [Abstract][Full Text] [Related]
6. Smurf2-Mediated Stabilization of DNA Topoisomerase IIα Controls Genomic Integrity.
Emanuelli A; Borroni AP; Apel-Sarid L; Shah PA; Ayyathan DM; Koganti P; Levy-Cohen G; Blank M
Cancer Res; 2017 Aug; 77(16):4217-4227. PubMed ID: 28611047
[TBL] [Abstract][Full Text] [Related]
7. Topoisomerase IIα prevents ultrafine anaphase bridges by two mechanisms.
Gemble S; Buhagiar-Labarchède G; Onclercq-Delic R; Fontaine G; Lambert S; Amor-Guéret M
Open Biol; 2020 May; 10(5):190259. PubMed ID: 32400307
[TBL] [Abstract][Full Text] [Related]
8. The α isoform of topoisomerase II is required for hypercompaction of mitotic chromosomes in human cells.
Farr CJ; Antoniou-Kourounioti M; Mimmack ML; Volkov A; Porter AC
Nucleic Acids Res; 2014 Apr; 42(7):4414-26. PubMed ID: 24476913
[TBL] [Abstract][Full Text] [Related]
9. Mitotic specific phosphorylation of serine-1212 in human DNA topoisomerase IIalpha.
Ishida R; Takashima R; Koujin T; Shibata M; Nozaki N; Seto M; Mori H; Haraguchi T; Hiraoka Y
Cell Struct Funct; 2001 Aug; 26(4):215-26. PubMed ID: 11699638
[TBL] [Abstract][Full Text] [Related]
10. Localisation of DNA topoisomerase IIalpha in mouse erythroleukemia cells.
Ivanova EC; Donev RM; Djondjurov LP
Mol Cells; 1999 Jun; 9(3):309-13. PubMed ID: 10420991
[TBL] [Abstract][Full Text] [Related]
11. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
[TBL] [Abstract][Full Text] [Related]
12. Enforced cytokinesis without complete nuclear division in embryonic cells depleting the activity of DNA topoisomerase IIalpha.
Akimitsu N; Adachi N; Hirai H; Hossain MS; Hamamoto H; Kobayashi M; Aratani Y; Koyama H; Sekimizu K
Genes Cells; 2003 Apr; 8(4):393-402. PubMed ID: 12653966
[TBL] [Abstract][Full Text] [Related]
13. Conjugation of human topoisomerase 2 alpha with small ubiquitin-like modifiers 2/3 in response to topoisomerase inhibitors: cell cycle stage and chromosome domain specificity.
Agostinho M; Santos V; Ferreira F; Costa R; Cardoso J; Pinheiro I; Rino J; Jaffray E; Hay RT; Ferreira J
Cancer Res; 2008 Apr; 68(7):2409-18. PubMed ID: 18381449
[TBL] [Abstract][Full Text] [Related]
14. DNA Topoisomerase IIα contributes to the early steps of adipogenesis in 3T3-L1 cells.
Jacobsen RG; Mazloumi Gavgani F; Mellgren G; Lewis AE
Cell Signal; 2016 Oct; 28(10):1593-603. PubMed ID: 27404349
[TBL] [Abstract][Full Text] [Related]
15. Selection of human leukemic CEM cells for resistance to the DNA topoisomerase II catalytic inhibitor ICRF-187 results in increased levels of topoisomerase IIalpha and altered G(2)/M checkpoint and apoptotic responses.
Morgan SE; Cadena RS; Raimondi SC; Beck WT
Mol Pharmacol; 2000 Feb; 57(2):296-307. PubMed ID: 10648639
[TBL] [Abstract][Full Text] [Related]
16. Deacetylase activity associates with topoisomerase II and is necessary for etoposide-induced apoptosis.
Johnson CA; Padget K; Austin CA; Turner BM
J Biol Chem; 2001 Feb; 276(7):4539-42. PubMed ID: 11136718
[TBL] [Abstract][Full Text] [Related]
17. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells.
Christensen MO; Larsen MK; Barthelmes HU; Hock R; Andersen CL; Kjeldsen E; Knudsen BR; Westergaard O; Boege F; Mielke C
J Cell Biol; 2002 Apr; 157(1):31-44. PubMed ID: 11927602
[TBL] [Abstract][Full Text] [Related]
18. The dynamics of DNA topoisomerase IIalpha in living cells.
Daum JR; Mo YY; Gorbsky GJ
Methods Mol Biol; 2009; 582():233-44. PubMed ID: 19763954
[TBL] [Abstract][Full Text] [Related]
19. Functional compatibility between isoform alpha and beta of type II DNA topoisomerase.
Sakaguchi A; Kikuchi A
J Cell Sci; 2004 Mar; 117(Pt 7):1047-54. PubMed ID: 14996935
[TBL] [Abstract][Full Text] [Related]
20. Ectopic expression of human topoisomerase IIalpha fragments and etoposide resistance in mammalian cells.
Ernst AI; Soltermann A; Sigrist JA; Widmer L; Gasser SM; Stahel RA
Int J Cancer; 2000 Oct; 88(1):99-107. PubMed ID: 10962446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]